|
WO2020085504A1
(ja)
|
2018-10-26 |
2020-04-30 |
大鵬薬品工業株式会社 |
光照射ザンドマイヤー反応を用いたクロロアゾールカルボキシレート誘導体の製造方法
|
|
MD4051678T2
(en)
|
2019-10-28 |
2026-07-31 |
Merck Sharp & Dohme Llc |
Small molecule inhibitors of the KRAS G12C mutant
|
|
WO2021085653A1
(en)
|
2019-10-31 |
2021-05-06 |
Taiho Pharmaceutical Co., Ltd. |
4-aminobut-2-enamide derivatives and salts thereof
|
|
EP4067343A4
(en)
|
2019-11-29 |
2024-01-03 |
Taiho Pharmaceutical Co., Ltd. |
NEW PHENOLIC COMPOUND OR SALT THEREOF
|
|
WO2021215544A1
(en)
|
2020-04-24 |
2021-10-28 |
Taiho Pharmaceutical Co., Ltd. |
Kras g12d protein inhibitors
|
|
US12702658B2
(en)
|
2020-04-24 |
2026-08-11 |
Taiho Pharmaceutical Co., Ltd. |
Anticancer combination therapy with N-(1-acryloyl-azetidin-3-yl)-2-((1H-indazol-3-yl)amino)methyl)-1H-imidazole-5-carboxamide inhibitor of KRAS-G12C
|
|
CA3191279A1
(en)
|
2020-08-28 |
2022-03-03 |
Yi Liu |
Heterocyclic compounds and uses thereof
|
|
WO2022109487A1
(en)
|
2020-11-23 |
2022-05-27 |
Merck Sharp & Dohme Corp. |
Spirocyclic-substituted 6,7-dihydro-pyrano[2,3-d]pyrimidine inhibitors of kras g12c mutant
|
|
KR20230169967A
(ko)
*
|
2021-03-12 |
2023-12-18 |
브리스톨-마이어스 스큅 컴퍼니 |
Kras g12d 억제제
|
|
EP4329888A1
(en)
*
|
2021-04-29 |
2024-03-06 |
Amgen Inc. |
2-aminobenzothiazole compounds and methods of use thereof
|
|
WO2022232331A1
(en)
*
|
2021-04-29 |
2022-11-03 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
|
CN117500799A
(zh)
*
|
2021-06-09 |
2024-02-02 |
伊莱利利公司 |
作为kras g12d抑制剂的取代的稠合吖嗪
|
|
CA3227138A1
(en)
*
|
2021-07-23 |
2023-01-26 |
Theras, Inc. |
Compositions and methods for inhibition of ras
|
|
WO2023039240A1
(en)
*
|
2021-09-13 |
2023-03-16 |
Biomea Fusion, Inc. |
IRREVERSIBLE INHIBITORS OF KRas
|
|
WO2023061294A1
(zh)
*
|
2021-10-13 |
2023-04-20 |
再鼎医药(上海)有限公司 |
含氮杂环类衍生物调节剂、其制备方法及应用
|
|
WO2023072188A1
(zh)
*
|
2021-10-29 |
2023-05-04 |
贝达药业股份有限公司 |
Kras g12d抑制剂及其在医药上的应用
|
|
WO2023103523A1
(zh)
*
|
2021-12-09 |
2023-06-15 |
苏州浦合医药科技有限公司 |
取代的双环杂芳基化合物作为kras g12d抑制剂
|
|
WO2023114733A1
(en)
*
|
2021-12-13 |
2023-06-22 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
AR128212A1
(es)
*
|
2022-01-06 |
2024-04-10 |
Theras Inc |
Composiciones y métodos para la inhibición de ras
|
|
AR128211A1
(es)
*
|
2022-01-06 |
2024-04-10 |
Theras Inc |
Composiciones y métodos para la inhibición de ras
|
|
WO2023138583A1
(zh)
*
|
2022-01-21 |
2023-07-27 |
上海湃隆生物科技有限公司 |
杂环类化合物、药物组合物及其应用
|
|
JP7629580B1
(ja)
|
2022-01-21 |
2025-02-13 |
ユーシノヴァ・ファーマシューティカルズ・リミテッド |
ベンゾピリミジン化合物及びその使用
|
|
IL314486A
(en)
*
|
2022-02-03 |
2024-09-01 |
Mirati Therapeutics Inc |
Quinazoline compounds inhibit PAN-KRAS
|
|
CA3243798A1
(en)
|
2022-02-09 |
2023-08-17 |
Quanta Therapeutics, Inc. |
Kras Modulators and Their Uses
|
|
JP2025508702A
(ja)
*
|
2022-02-16 |
2025-04-10 |
アムジエン・インコーポレーテツド |
キナゾリン化合物、及び変異krasタンパク質の阻害剤としてのその使用
|
|
CN118715215A
(zh)
*
|
2022-02-16 |
2024-09-27 |
美国安进公司 |
作为突变kras蛋白抑制剂的喹唑啉化合物及其用途
|
|
WO2023172737A1
(en)
|
2022-03-11 |
2023-09-14 |
Kumquat Biosciences Inc. |
Heterocyclic compounds and uses thereof
|
|
JP2025510656A
(ja)
*
|
2022-03-24 |
2025-04-15 |
ベイジーン スウィッツァーランド ゲーエムベーハー |
複素環式化合物、その組成物、及びそれらを用いた治療方法
|
|
CN116891488B
(zh)
*
|
2022-04-11 |
2025-12-12 |
成都海博为药业有限公司 |
稠环化合物、包含其的药物组合物及应用
|
|
WO2023225252A1
(en)
*
|
2022-05-20 |
2023-11-23 |
Theras, Inc. |
Compositions and methods for inhibition of ras
|
|
WO2023230190A1
(en)
|
2022-05-25 |
2023-11-30 |
Quanta Therapeutics, Inc. |
Pyrimidine based modulators and uses thereof
|
|
WO2023246777A1
(en)
*
|
2022-06-20 |
2023-12-28 |
Jacobio Pharmaceuticals Co., Ltd. |
K-ras mutant protein inhibitors
|
|
WO2024008179A1
(en)
*
|
2022-07-07 |
2024-01-11 |
Beigene, Ltd. |
Heterocyclic compounds, compositions thereof, and methods of treatment therewith
|
|
US20260035376A1
(en)
|
2022-08-05 |
2026-02-05 |
Theras, Inc. |
Compositions and methods for inhibition of ras
|
|
AU2023320565A1
(en)
|
2022-08-05 |
2025-01-23 |
Kumquat Biosciences Inc. |
Heterocyclic compounds and uses thereof
|
|
CN120019052A
(zh)
*
|
2022-08-05 |
2025-05-16 |
瑟拉斯有限公司 |
用于抑制kras的组合物和方法
|
|
EP4577214A2
(en)
*
|
2022-08-26 |
2025-07-02 |
Merck Sharp & Dohme LLC |
Small molecule inhibitors of kras proteins
|
|
WO2024063576A1
(ko)
*
|
2022-09-23 |
2024-03-28 |
일동제약(주) |
Kras 저해 물질로서 신규한 퀴나졸린 화합물
|
|
WO2024083246A1
(en)
*
|
2022-10-21 |
2024-04-25 |
Ascentage Pharma (Suzhou) Co., Ltd. |
Kras inhibitors
|
|
JP2025539080A
(ja)
*
|
2022-11-14 |
2025-12-03 |
アムジエン・インコーポレーテツド |
大環状kras阻害剤及び使用方法
|
|
CN116554208A
(zh)
*
|
2022-12-02 |
2023-08-08 |
苏州浦合医药科技有限公司 |
取代的双环杂芳基化合物作为kras g12d抑制剂
|
|
CN116082115A
(zh)
*
|
2023-01-06 |
2023-05-09 |
河南省科学院化学研究所有限公司 |
一种2-溴-4-氯-9,9’-二甲基芴的合成方法
|
|
EP4680609A1
(en)
|
2023-03-15 |
2026-01-21 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
US20240343736A1
(en)
*
|
2023-03-30 |
2024-10-17 |
Eli Lilly And Company |
Kras inhibitors
|
|
WO2024243025A1
(en)
*
|
2023-05-19 |
2024-11-28 |
Ikena Oncology, Inc. |
Naphthyl-substituted pyrido[4,3-d]pyrimidines and related compounds and their use in treating medical conditions
|
|
WO2025002430A1
(zh)
*
|
2023-06-29 |
2025-01-02 |
西藏海思科制药有限公司 |
一种5元杂芳基衍生物及其在医药上的应用
|
|
EP4735451A1
(en)
|
2023-06-30 |
2026-05-06 |
Kumquat Biosciences Inc. |
Substituted condensed tricyclic amine compounds and uses thereof as ras inhibitors
|
|
WO2025019823A1
(en)
*
|
2023-07-20 |
2025-01-23 |
Merck Sharp & Dohme Llc |
Small molecule protein degraders of kras g12d mutant
|
|
WO2025049402A1
(en)
*
|
2023-08-28 |
2025-03-06 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
AU2024337016A1
(en)
*
|
2023-09-08 |
2026-04-16 |
Tyligand Bioscience (Shanghai) Limited |
Ras inhibitor
|
|
US20250109147A1
(en)
|
2023-09-08 |
2025-04-03 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
TW202523324A
(zh)
*
|
2023-10-08 |
2025-06-16 |
大陸商成都海博為藥業有限公司 |
一種稠環化合物及應用
|
|
US20250114346A1
(en)
|
2023-10-09 |
2025-04-10 |
Incyte Corporation |
Combination therapy using a kras g12d inhibitor and pd-1 inhibitor or pd-l1 inhibitor
|
|
KR20260110993A
(ko)
|
2023-10-09 |
2026-07-14 |
인사이트 코포레이션 |
Kras g12d 억제제 및 egfr 억제제를 포함하는 암 치료용 조합
|
|
KR20260096846A
(ko)
|
2023-10-20 |
2026-06-24 |
머크 샤프 앤드 돔 엘엘씨 |
Kras 단백질의 소분자 억제제
|
|
KR20260102810A
(ko)
*
|
2023-10-25 |
2026-07-01 |
컴쿼트 바이오사이언시즈 인크. |
세포 증식을 조절하는 방법
|
|
WO2025117828A1
(en)
*
|
2023-12-01 |
2025-06-05 |
Theras, Inc. |
Compositions and methods for inhibition of ras
|
|
WO2026090333A1
(en)
|
2024-10-23 |
2026-04-30 |
Incyte Corporation |
Combination using a kras g12d inhibitor and chemotherapy combinations as well as their use in the treatment of cancer
|
|
US20260137674A1
(en)
|
2024-10-23 |
2026-05-21 |
Incyte Corporation |
Combination therapy using a kras g12d inhibitor, and a nucleoside analog, and/or a microtubule inhibitor
|